Ovid Therapeutics Inc.OVIDNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-57.77M
↓ 70% below average
Average (9y)
$-34.00M
Historical baseline
Range
High:$124.45M
Low:$-81.12M
CAGR
+17.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-57.77M | -1.3% |
| 2023 | $-57.01M | -5.3% |
| 2022 | $-54.17M | -143.5% |
| 2021 | $124.45M | +253.4% |
| 2020 | $-81.12M | -32.7% |
| 2019 | $-61.15M | -15.8% |
| 2018 | $-52.79M | +18.4% |
| 2017 | $-64.73M | -187.9% |
| 2016 | $-22.48M | -70.6% |
| 2015 | $-13.18M | - |